Production (Stage)
Connect Biopharma Holdings Limited
CNTB
$0.9799
$0.02993.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.16% | 26.41% | 26.41% | 125.10% | 42.95% |
| Total Depreciation and Amortization | 5.49% | -13.62% | -13.62% | -6.11% | -35.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.75% | 64.84% | 64.84% | 146.15% | 237.09% |
| Change in Net Operating Assets | -108.75% | -79.60% | -79.60% | -833.77% | 800.52% |
| Cash from Operations | -1,585.11% | 5.72% | 5.72% | 74.41% | 96.21% |
| Capital Expenditure | -- | -250.96% | -250.96% | -50.87% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -322.29% | -137.89% | -137.89% | -63.02% | -46.18% |
| Cash from Investing | -323.15% | -138.46% | -138.46% | -63.98% | -45.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 2.78% | 2.78% | -2.78% | -- |
| Issuance of Common Stock | -- | 443.48% | 443.48% | 363.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 63.47% | 63.47% | 62.30% | -- |
| Foreign Exchange rate Adjustments | 133.94% | -41.85% | -41.85% | 57.55% | -108.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -461.73% | -231.02% | -231.02% | 60.33% | 549.33% |